London, UK – March 09th, 2026 – Qinecsa, the global class leader in technology-powered pharmacovigilance solutions, has announced the release of HaloPV 6.2, the latest update to its
Alex will drive global commercial strategy and help scale Qinecsa’s next-generation pharmacovigilance technology across the life sciences ecosystem London, UK – January 12th, 2025 – Qinecsa, the
Beena Wood will build on the pure-bred pharmacovigilance specialist’s deep domain expertise and technology-powered solution portfolio to help reframe the contribution of drug safety London,
As the year comes to a close, Qinecsa reflects on a successful 2025 filled with global engagement and innovation in pharmacovigilance. Our team participated in key industry events across North
John Cogan has a degree in chemistry and could easily have become a scientist. However, he was always more fascinated by technology than the laboratory
Qinecsa is thrilled to be exhibiting at the DIA EU, from March 18-20 2025 in Basel, Switzerland. DIA Europe 2025 will focus on sustainability, innovation
Pharmaceutical Technology continues its insightful conversation with Qinecsa Solutions‘ Adam Sherlock examining how shifting political landscapes in the US and Europe could reshape the bio/pharma
Industry Insights – Pharmaceutical Technology talks to Qinecsa Solutions‘ CEO, Adam Sherlock about the outlook for the Life Sciences industry in 2025, focusing in on
On The Agenda: Introduction Tackling Compliance and Global Challenges: Key regulatory requirements (e.g. EMA) and best practices – Strategies for addressing global surveillance complexities Next-
Qinecsa is thrilled to be exhibiting at the DIA Global Pharmacovigilance & Risk Management Strategies Conference, from January 27-29 2025 in Baltimore, MD. DIA’s Global
